These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1372269)

  • 41. The clinical use of RHG-CSF for malignant lymphomas.
    Oyama A; Suzuki H; Ogura M; Ariyoshi Y; Asano S
    J Nutr Sci Vitaminol (Tokyo); 1992; Spec No():361-4. PubMed ID: 1284307
    [No Abstract]   [Full Text] [Related]  

  • 42. Recombinant granulocyte-macrophage colony-stimulating factor (rGM-CSF): an appraisal of its pharmacoeconomic status in neutropenia associated with chemotherapy and autologous bone marrow transplant.
    Goa KL; Bryson HM
    Pharmacoeconomics; 1994 Jan; 5(1):56-77. PubMed ID: 10146867
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Reversal of gold-induced neutropenia with granulocyte colony-stimulating factor (G-CSF).
    Collins DA; Tobias JH; Hill RP; Bourke BE
    Br J Rheumatol; 1993 Jun; 32(6):518-20. PubMed ID: 7685228
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Granulocyte-colony stimulating factor-induced proliferation of primary adult T-cell leukaemia cells.
    Matsushita K; Arima N; Ohtsubo H; Fujiwara H; Hidaka S; Kukita T; Suruga Y; Fukumori J; Matsumoto T; Kanzaki A; Yawata Y; Tanaka H
    Br J Haematol; 1997 Mar; 96(4):715-23. PubMed ID: 9074411
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Recombinant human granulocyte colony-stimulating factor attenuates inflammatory responses in septic patients with neutropenia.
    Ishikawa K; Tanaka H; Matsuoka T; Shimazu T; Yoshioka T; Sugimoto H
    J Trauma; 1998 Jun; 44(6):1047-54; discussion 1054-5. PubMed ID: 9637161
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Granulocyte colony-stimulating factor treatment for cyclophosphamide-induced severe neutropenia in Wegener's granulomatosis.
    Hellmich B; Schnabel A; Gross WL
    Arthritis Rheum; 1999 Aug; 42(8):1752-6. PubMed ID: 10446877
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical use of subcutaneous G-CSF or GM-CSF in malignancy.
    Disis ML
    Oncology (Williston Park); 2005 Apr; 19(4 Suppl 2):5-9. PubMed ID: 15934493
    [No Abstract]   [Full Text] [Related]  

  • 48. Transient hypoxaemia during neutrophil recovery in febrile patients.
    White K; Cebon J
    Lancet; 1995 Apr; 345(8956):1022-4. PubMed ID: 7536871
    [TBL] [Abstract][Full Text] [Related]  

  • 49. An open-label multicenter safety, tolerability, and efficacy study of recombinant granulocyte colony-stimulating factor in the prevention of neutropenic complications in breast cancer patients.
    Sveikata A; Liutkauskienė S; Juozaitytė E; Characiejus D; Tamošaitytė L; Šeštakauskas K
    Medicina (Kaunas); 2011; 47(8):428-33. PubMed ID: 22123557
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Recombinant granulocyte colony-stimulating factor (rG-CSF) in the management of neutropenia induced by anthracyclines and ifosfamide in patients with soft tissue sarcomas (NEUSAR).
    Bongiovanni A; Monti M; Foca F; Recine F; Riva N; Di Iorio V; Liverani C; De Vita A; Miserocchi G; Mercatali L; Amadori D; Ibrahim T
    Support Care Cancer; 2017 Jan; 25(1):111-117. PubMed ID: 27568305
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Granulocyte colony-stimulating factor for hepatitis C therapy-associated neutropenia: systematic review and economic evaluation.
    Tandon P; Doucette K; Fassbender K; Vandermeer B; Durec T; Dryden DM
    J Viral Hepat; 2011 Jul; 18(7):e381-93. PubMed ID: 21692951
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prophylactic long-acting granulocyte-colony stimulating factors (G-CSF) in gynecologic malignancies: an oncologic expert statement.
    Petru E; Singer CF; Polterauer S; Galid A; Schauer C; Klocker J; Seifert M; Reinthaller A; Benedicic C; Hubalek M; Hefler L; Marth C; Scholl-Firon T; Bogner G; Zeimet AG
    Wien Med Wochenschr; 2015 Oct; 165(19-20):387-94. PubMed ID: 26471371
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [A double-blind, cross-over clinical trial of recombinant human G-CSF on neutropenia induced by chemotherapy for non-Hodgkin's lymphoma].
    Oyama A; Ota K; Asano S; Takaku F; Yoshida Y; Uzuka Y; Omine M; Furusawa S; Takatani O; Sawada U
    Nihon Gan Chiryo Gakkai Shi; 1990 Oct; 25(10):2533-48. PubMed ID: 1702132
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In vitro and in vivo effects of granulocyte colony-stimulating factor on neutrophils in glycogen storage disease type 1B: granulocyte colony-stimulating factor therapy corrects the neutropenia and the defects in respiratory burst activity and Ca2+ mobilization.
    McCawley LJ; Korchak HM; Douglas SD; Campbell DE; Thornton PS; Stanley CA; Baker L; Kilpatrick L
    Pediatr Res; 1994 Jan; 35(1):84-90. PubMed ID: 7510873
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Reversal of radiation-induced neutropenia by granulocyte colony-stimulating factor.
    Marks LB; Friedman HS; Kurtzberg J; Oakes WJ; Hockenberger BM
    Med Pediatr Oncol; 1992; 20(3):240-2. PubMed ID: 1374149
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Recombinant granulocyte colony-stimulating factor (rG-CSF): pharmacoeconomic considerations in chemotherapy-induced neutropenia.
    Faulds D; Lewis NJ; Milne RJ
    Pharmacoeconomics; 1992 Apr; 1(4):231-49. PubMed ID: 10147015
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Neutropenia related to valacyclovir and valganciclovir in 2 renal transplant patients and treatment with granulocyte colony stimulating factor: a case report.
    Keles M; Yildirim R; Uyanik A; Turkmen M; Bilen Y; Aydinli B; Cetinkaya R; Polat KY
    Exp Clin Transplant; 2010 Jun; 8(2):181-3. PubMed ID: 20565377
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Differential effect of G-CSF and GM-CSF in acquired chronic neutropenia.
    Wodzinski MA; Hampton KK; Reilly JT
    Br J Haematol; 1991 Feb; 77(2):249-50. PubMed ID: 1706198
    [No Abstract]   [Full Text] [Related]  

  • 59. Effects of a formulary change from granulocyte colony-stimulating factor to granulocyte-macrophage colony-stimulating factor on outcomes in patients treated with myelosuppressive chemotherapy.
    Wong SF; Chan HO
    Pharmacotherapy; 2005 Mar; 25(3):372-8. PubMed ID: 15843284
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The efficacy of recombinant human granulocyte colony-stimulating factor and recombinant human granulocyte macrophage colony-stimulating factor in permitting the administration of higher doses of cyclophosphamide in a doxorubicin-cyclophosphamide combination. An NSABP pilot study in patients with metastatic or high-risk primary breast cancer. National Surgical Adjuvant Breast and Bowel Project.
    Mamounas EP; Anderson S; Wickerham DL; Clark R; Stoller R; Hamm JT; Stewart JA; Bear HD; Glass AG; Bornstein R
    Am J Clin Oncol; 1994 Oct; 17(5):374-81; discussion 382. PubMed ID: 7522393
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.